سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Recent breakthroughs in drug delivery systems for targeted cancer therapy: an overview

Publish Year: 1404
Type: Journal paper
Language: English
View: 74

This Paper With 15 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_CMBR-5-1_002

Index date: 6 October 2024

Recent breakthroughs in drug delivery systems for targeted cancer therapy: an overview abstract

Targeted drug delivery systems have emerged as promising approaches for improving the efficacy and safety of cancer therapy. This review highlights recent advancements in drug delivery technologies aimed at achieving targeted and personalized treatment strategies for cancer patients. The integration of nanotechnology, biomaterials, and molecular targeting strategies has enabled the development of sophisticated drug delivery systems capable of selectively delivering therapeutic agents to tumour tissues while minimizing off-target effects on healthy tissues. Various targeting mechanisms, including passive and active targeting strategies, exploit the unique physiological characteristics of tumours, such as abnormal vasculature, overexpressed receptors, and altered microenvironments, to achieve selective accumulation and retention of drugs within tumour tissues. Nanoparticle-based drug delivery systems, such as liposomes, polymeric nanoparticles, and inorganic nanoparticles, offer advantages in terms of drug loading capacity, sustained release, and tumour targeting, making them attractive platforms for targeted cancer therapy. Moreover, the integration of smart drug delivery systems that respond to specific stimuli within the tumor microenvironment, such as pH, temperature, or enzyme activity, holds promise for enhancing tumor specificity and reducing systemic toxicity. Combination therapy approaches, which combine targeted drug delivery with other therapeutic modalities, such as immunotherapy or photodynamic therapy, offer synergistic effects and opportunities for overcoming treatment resistance. Despite these advancements, several challenges remain, including the translation of preclinical research findings into clinically viable therapies, regulatory approval, manufacturing scalability, and biomarker discovery. Addressing these challenges and embracing innovative approaches will be essential for realizing the full potential of targeted drug delivery systems in improving patient outcomes and advancing cancer therapy.

Recent breakthroughs in drug delivery systems for targeted cancer therapy: an overview Keywords:

Recent breakthroughs in drug delivery systems for targeted cancer therapy: an overview authors

Konatham Reddy

Department of Pharmacy, University College of Technology, Osmania University Main Road, Amberpet, Hyderabad ۵۰۰۰۰۷, India

Alapati Reddy

Department of Pharmaceutical Analysis, Nalla Narasimha Reddy Education Society's Group of Institutions, Via Narapally, Ghatkesar Mandal, Korremula Rd, Hyderabad, Telangana ۵۰۰۰۸۸, India

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Zahavi D, Weiner L (۲۰۲۰) Monoclonal antibodies in cancer therapy. ...
Tam KY, Leung KC-F, Wang Y-XJ (۲۰۱۱) Chemoembolization agents for ...
Haque M, Shakil MS, Mahmud KM (۲۰۲۳) The Promise of ...
Xiong HM (۲۰۱۳) ZnO nanoparticles applied to bioimaging and drug ...
Ko W, Jung N, Lee M, Yun M, Jeon S ...
Khajeh H, Bahman Fazeli N, Mirzaei AR, Farzanfar H (۲۰۲۳) ...
Liu D, Wu W, Qiu Y, Yang S, Xiao S, ...
Hong H, Wang F, Zhang Y, Graves SA, Eddine SBZ, ...
Anselmo AC, Mitragotri S (۲۰۱۷) Impact of particle elasticity on ...
Guo D, Xie G, Luo J (۲۰۱۳) Mechanical properties of ...
Yi X, Shi X, Gao H (۲۰۱۱) Cellular uptake of ...
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, ...
Rao PV, Sanjeeva Reddy CK, Kumar MR, Rao DD (۲۰۱۲) ...
Vadagam N, Haridasyam SB, Venkatanarayana M, Lakka NS, Chinnakadoori SR ...
Vadagam N, Haridasyam SB, Venkatanarayana M, Lakka NS, Chinnakadoori SR ...
Lakka NS, Kuppan C, Vadagam N, Ravinathan P, Chepuri K, ...
Vadagam N, Haridasyam SB, Venkatanarayana M, Lakka NS, Chinnakadoori SR ...
Best JP, Yan Y, Caruso F (۲۰۱۲) The role of ...
Hui Y, Wibowo D, Liu Y, Ran R, Wang H-F, ...
Ma K, Xu S, Tao T, Qian J, Cui Q, ...
Pasham M, Haridasyam SB, Vadagam N, Boppy NP, Chinnakadoori SR, ...
Reddy KTK, Haque MA (۲۰۲۲) Develop and validate a highly ...
Hasan N, Imran M, Jain D, Jha SK, Nadaf A, ...
Junyaprasert VB, Thummarati P (۲۰۲۳) Innovative Design of Targeted Nanoparticles: ...
Mahdieh A, Yeganeh H, Motasadizadeh H, Nekoueifard E, Maghsoudian S, ...
Chen Y, Liu S, Liang J, Zhu H (۲۰۲۲) Evaluating ...
Paresishvili T, Kakabadze Z (۲۰۲۳) Challenges and Opportunities Associated With ...
Reddy KTK, Gandla K, Babu PV, Chakravarthy MVK, Chandrasekhar P, ...
Ivanova-Radkevich VI (۲۰۲۲) Biochemical Basis of Selective Accumulation and Targeted ...
Li M, Mei S, Yang Y, Shen Y, Chen L ...
Cheng HT, Ngoc Ta YN, Hsia T, Chen Y (۲۰۲۴) ...
Wang Y, Jiang H, Zhang L, Yao P, Wang S, ...
Wu D, Chen Q, Chen X, Han F, Chen Z, ...
Agwa MM, Elmotasem H, Elsayed H, Abdelsattar AS, Omer AM, ...
Ho ECH, Qiu R, Miller E, Bilotta MT, FitzGerald D, ...
Cohen L, Livney YD, Assaraf YG (۲۰۲۱) Targeted nanomedicine modalities ...
Raucher D, Dragojevic S, Ryu J (۲۰۱۸) Macromolecular Drug Carriers ...
Mishra AK, Pandey M, Dewangan HK, Sl N, Sahoo PK ...
Song M, Cao R, Chen X, Wang C, Xing X, ...
Junyaprasert VB, Thummarati P (۲۰۲۳) Innovative Design of Targeted Nanoparticles: ...
Quinonero G, Gallo J, Carrasco A, Samitier J, Villasante A ...
Yadav R, Das PP, Sharma S, Sengupta S, Kumar D, ...
Shen Z, Song J, Yung BC, Zhou Z, Wu A, ...
Xie Y, Hou W, Song X, Yu Y, Huang J, ...
Zhou H, Lu X, Du C, Zhou Z, Feng J, ...
Biffi S, Voltan R, Bortot B, Zauli G, Secchiero P ...
Roex MC, Hageman L, Veld SA, van Egmond E, Hoogstraten ...
Greiner J, Schmitt M, Li L, Giannopoulos K, Bosch K, ...
Seeger RC Immunology and immunotherapy of neuroblastoma. In: Seminars in ...
Su Y, Zhang X, Bidlingmaier S, Behrens CR, Lee N-K, ...
Capece D, Verzella D, Fischietti M, Zazzeroni F, Alesse E ...
Schwartz RH (۲۰۰۳) T cell anergy. Annual review of immunology ...
Li S-Y, Liu Y (۲۰۱۳) Immunotherapy of melanoma with the ...
Zou T-B, He T-P, Li H-B, Tang H-W, Xia E-Q ...
Zhang L, Yin G, Yan D, Wei Y, Ma C, ...
Saw PE, Song E-W (۲۰۱۹) Phage display screening of therapeutic ...
Dmitrieva MD, Voitova AA, Dymova MA, Richter VA, Kuligina EV ...
Qu X, Qiu P, Zhu Y, Yang M, Mao C ...
Ma C, Yin G, Yan D, He X, Zhang L, ...
Scodeller P, Simón-Gracia L, Kopanchuk S, Tobi A, Kilk K, ...
Zhang C, Wu W, Li RQ, Qiu WX, Zhuang ZN, ...
Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, ...
Van Cutsem E, Peeters M, Siena S, Humblet Y, Hendlisz ...
Yadav B, Chauhan M, Singh RP, Sonali, Shekhar S (۲۰۲۴) ...
Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, ...
Kostadinov K, Marinova Y, Dimitrov K, Hristova-Atanasova E, Iskrov G, ...
نمایش کامل مراجع